Supravalvular Aortic Stenosis #4 Surgical Repair

1) Core objective (what the operation must accomplish)

SVAS repair is not merely “gradient reduction.” The operation should reconstruct the sinotubular junction (STJ) and proximal ascending aorta into a symmetric, physiologic root–STJ geometry, while preserving two non-negotiables: (i) aortic valve competence and (ii) coronary ostial integrity/flow. This geometry-first concept explains why multi-sinus reconstructions often provide more durable relief than limited, asymmetric enlargement strategies. [1,2]

Primary targets

• Symmetric STJ circumference (avoid eccentric residual narrowing and turbulence). [1,2]
• Commissural alignment + leaflet coaptation (prevent geometry-driven AR). [1]
• Coronary safety (avoid traction, kinking, iatrogenic ostial narrowing). [1,3]
• No “new bottleneck”: if disease extends beyond the reconstructed root/STJ, augment the proximal ascending aorta to avoid a second-level obstruction. [1]

2) Preoperative planning (define the phenotype before bypass)

1. Level and extent of obstruction
• STJ-limited (“hourglass”) vs diffuse AAo hypoplasia (and whether the sinuses are involved). [1,3]
2. Coronary anatomy and perfusion risk
• SVAS can behave like a coronary perfusion disease, not just an afterload lesion; coronary ostial stenosis and coronary flow vulnerability are clinically relevant. [3]
3. Associated lesions (plan a one-stage rehabilitation when appropriate)
• Arch pathology (coarctation/hypoplasia) and branch PA stenoses (particularly in elastin-arteriopathy phenotypes) should be actively screened and addressed when anatomy/physiology support a combined approach. [1,8]

3) Operative principles (technical “rules of the road”)

• Symmetry matters: avoid creating an eccentric STJ that leaves residual gradient or promotes late distortion. [2,4]
• Commissures are sacred: patch geometry should enlarge sinuses/STJ without commissural malalignment. [1]
• Respect the coronaries: incision lines and patch height must not displace or narrow coronary ostia. [1,3]
• Match repair to disease extent: isolated sinus augmentation is insufficient when stenosis extends into the AAo; add AAo augmentation as needed. [1]

4) Major repair families (what “McGoon / Doty / Brom” really mean)

Contemporary series and reviews consistently frame SVAS repair as single-patch vs multi-sinus reconstruction, with durable outcomes generally favoring broader, more symmetric enlargement. [1,2,4,11]

4.1 Single-patch aortoplasty (McGoon)

Concept: longitudinal incision across the narrowed segment with one patch augmentation. [1]

Strengths

• Simple and rapid in selected focal lesions.

Limitations

• Often asymmetric enlargement → higher likelihood of residual gradient or later reintervention in comparative cohorts. [4,11]

Best fit

• Truly focal SVAS with favorable sinus/coronary geometry and adequate circumferential gain. [1]

4.2 Two-sinus “pantaloon” patch (Doty)

Concept: a pantaloon/Y-shaped patch extending into two sinuses (classically right coronary + noncoronary), enlarging the STJ with a smoother sinus-to-STJ transition than single patch. [1]

Why it works

• Larger effective circumference gain at the STJ than single patch, often translating into better durability in comparative studies. [4,5,11]

Technical emphasis

• Eliminate dog-ears/ridges; ensure a smooth, laminar sinus contour; protect coronary geometry. [1]

4.3 Three-sinus symmetric aortoplasty (Brom)

Concept: separate patch augmentation of all three sinuses to recreate the most symmetric, root-like geometry. [1]

Rationale

• SVAS is frequently a root–STJ geometric disease; Brom most directly restores symmetry. [1,2]

Where it is especially attractive

• Multi-sinus involvement, marked STJ hypoplasia, diffuse morphology where partial enlargement risks eccentric flow. [1,2]

Common refinement

• Add proximal AAo augmentation if the AAo remains small beyond the reconstructed STJ, preventing a “second-level” obstruction. [1]

Important nuance: some institutional series report similarly good outcomes between 2-sinus and 3-sinus reconstructions, suggesting that achieved symmetry and disease phenotype may matter more than the label of the technique itself. [6]

5) Patch strategy (material and geometry)

Patch choice varies (autologous pericardium, treated pericardium, bovine pericardium, synthetics), but the decisive determinants of hemodynamics are typically geometry and tailoring: contour restoration, avoidance of puckering, and generous STJ circumference. [1,10]

Evidence trend (middle-term data)

• A multicenter cohort evaluating patch materials reported acceptable safety overall, with lower reoperation/restenosis rates in patients receiving pericardial patches compared with alternative patch categories at mid-term follow-up. [12]

6) Outcomes and “what the literature is telling us now”

Long-term survival is excellent, but SVAS remains a lifelong surveillance disease because reintervention is not rare, especially in diffuse disease or smaller baseline dimensions. [2,3,7]

Key quantitative signals from contemporary syntheses and cohorts:

• Pooled analyses and modeling suggest ~90–97% long-term survival, with a substantial lifetime reintervention risk (e.g., ~30% at long horizons in large pooled datasets). [2]
• Comparative cohorts show higher reoperation rates after single-patch repair relative to multi-sinus reconstructions in some experiences. [4,11]
• Predictors repeatedly associated with reintervention include:
• Younger age (especially infancy) [3,6]
• Smaller aortic valve/aortic root dimensions (z-scores) [3]
• Diffuse disease phenotype / associated outflow lesions [3,8]

Williams syndrome cohorts demonstrate excellent early survival, but late events and morbidity still justify structured follow-up. [7]

7) Follow-up priorities (what to watch over time)

1. Residual/recurrent obstruction (STJ and proximal AAo gradients; cross-sectional imaging when anatomy is complex). [2,3]
2. Aortic valve function (AR can be geometry-driven even when leaflets are normal). [1,3]
3. Coronary perfusion concerns (symptoms, ischemia evaluation in selected patients, imaging when indicated). [3,7]
4. Progressive arteriopathy in syndromic/elastin phenotypes (arch/branch PA disease may evolve). [7,8]

References

[1] Ibarra C, Spigel Z, John R, Binsalamah ZM, Adachi I, Heinle JS, Caldarone CA, McKenzie ED, Imamura M. Surgical Techniques in Management of Supravalvular Aortic Stenosis in Children. Ann Thorac Surg. 2021;111(6):2021-2027.

[2] Meccanici F, Notenboom ML, Meijssen J, Smit V, van de Woestijne PC, van den Bosch AE, Helbing WA, Bogers AJJC, Takkenberg JJM, Roos-Hesselink JW. Long-term surgical outcomes of congenital supravalvular aortic stenosis: a systematic review, meta-analysis and microsimulation study. Eur J Cardiothorac Surg. 2024;65(1):ezad360.

[3] Wu FY, Mondal A, Del Nido PJ, Gauvreau K, Emani SME, Baird CW, Kaza AK. Long-term Surgical Prognosis of Primary Supravalvular Aortic Stenosis Repair. Ann Thorac Surg. 2019;108(4):1202-1209.

[4] Kaushal S, Backer CL, Patel JN, Patel SK, Kaushal S. Midterm outcomes in supravalvular aortic stenosis demonstrate the superiority of multisinus aortoplasty. Ann Thorac Surg. 2010;89(5):1371-1377.

[5] Işık O, Akyüz M, Karakuş E, Işık E, Ayık MF, Levent E, Atay Y. Early and mid-term outcomes after surgical repair of congenital supravalvular aortic stenosis with the Doty technique. Turk Kardiyol Dern Ars. 2018;46(5):385-391.

[6] Kramer P, Absi D, Hetzer R, Photiadis J, Berger F, Alexi-Meskishvili V. Outcome of surgical correction of congenital supravalvular aortic stenosis with two- and three-sinus reconstruction techniques. Ann Thorac Surg. 2014;97(2):634-640.

[7] Fricke TA, d'Udekem Y, Brizard CP, Wheaton G, Weintraub RG, Konstantinov IE. Surgical repair of supravalvular aortic stenosis in children with williams syndrome: a 30-year experience. Ann Thorac Surg. 2015;99(4):1335-1341.

[8] Hu J, Chen H, Dong W, Hu R, Zhang W, Jiang Q, Zhang H. Midterm Results and Predictors for the Postoperative Vascular Stenosis of Supravalvular Aortic Stenosis. Semin Thorac Cardiovasc Surg. 2021;33(4):1069-1079.

[9] Scott DJ, Campbell DN, Clarke DR, Goldberg SP, Karlin DR, Mitchell MB. Twenty-year surgical experience with congenital supravalvar aortic stenosis. Ann Thorac Surg. 2009;87(5):1501-1507.

[10] Bakhtiary F, Amer M, Etz CD, et al. Mid-term outcome after surgical repair of congenital supravalvular aortic stenosis by extended aortoplasty. Interact Cardiovasc Thorac Surg. 2013;17(4):688-693.

[11] Lv L, Lang X, Zhang S, Wang C, Wang Q. Assessment of three types of surgical procedures for supravalvar aortic stenosis: A systematic review and meta-analysis. Front Cardiovasc Med. 2022;9:987522.

[12] Lang X, et al. Effectiveness and Safety of Different Patch Materials for Supravalvar Aortic Stenosis (Middle-Term Outcomes). Rev Cardiovasc Med. 2024;25(1):14.